Category: NeurometrixSyndicate content

NeuroMetrix signs distribution deal with DJO Global

February 10, 2014 by Chris Walker

DJO Global inks a deal to distribute the NeuroMetrix Sensus pain management device in the U.S.

NeuroMetrix signs distribution deal with DJO Global

NeuroMetrix (NSDQ:NURO) said it signed a national distribution deal with DJO Global for its Sensus pain management system.

Diabetes: NeuroMetrix gains on Chinese distribution deal

December 13, 2013 by Chris Walker

NeuroMetrix shares gain after it announces a distribution deal in China for its NC-stat DPNCheck diabetic peripheral neuropathy device.

Diabetes: NeuroMetrix gains on Chinese distribution deal

NeuroMetrix (NSDQ:NURO) said it inked a deal with Omron Medical Devices, a subsidiary of Omron Healthcare China, for the distribution rights to NeuroMetrix's NC-stat DPNCheck in China.

NeuroMetrix falls despite narrowed Q3 losses

October 25, 2013 by Chris Walker

Shares of NeuroMetrix fall more than 4% despite narrower 3rd-quarter losses as investors react to a more than 25% top-line slide.

NeuroMetrix falls despite narrowed Q3 losses

NeuroMetrix (NSDQ:NURO) shares lost more than 4% of their value yesterday after the medical device company reported a more than 25% sales slide during the 3rd quarter.

FDA green-lights NeuroMetrix pain treatment device for bed-time use

July 12, 2013 by Sony Salzman

NeuroMetrix wins FDA clearance to market its Sensus neurostimulation device for pain management during sleep.

NeuroMetrix's Sensus

NeuroMetrix's (NSDQ:NURO) Sensus wearable pain management device can now be paired with pajamas thanks to the FDA's clearance of the device for use during sleep.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Delcath to pare 20% of its U.S. workforce | Personnel Moves

July 2, 2013 by Sony Salzman

Delcath Systems announces that it will lay off about 20% of its U.S. employees and redouble its efforts in Europe.

fired/hired

Queensbury, N.Y.-based Delcath (NSDQ:DCTH) announced last week that it plans to pare its workforce by about 20%, the latest in a series of layoff announcements from the oncology devices maker. This is the 3rd time this year that Delcath has announced imminent layoffs, having announced smaller cuts in April and larger layoffs in January.

Greatbatch raises 2013 guidance on restructuring efforts | Wall Street Beat

June 6, 2013 by Arezu Sarvestani

Greatbatch merges its sales, marketing and operations with subsidiary Electrochem in the interest of shifting from sub-assemblies to complete medical devices, raising its 2013 per-share earnings guidance.

MassDevice.com Wall Street Beat

Texas medical device maker Greatbatch (NYSE:GB) raised its 2013 per-share earnings guidance as it announced new efforts to reorganize some of its business practices and reduce costs as it shifts from a components and sub-assemblies company to a developer of full medical devices.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp